New PET radiotracer to visualize cannabinoid receptors developed

Xagena.it, Italy
08/12/06

Researchers of Johns Hopkins developed a new radiotracer to visualize and quantify the brain's cannabinoid receptors by positron emission tomography ( PET ), opening a door to the development of new medications to treat drug dependence, obesity, depression, schizophrenia, Parkinson's disease and Tourette syndrome.